Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ironwood Pharma (IRWD) and Ovid Therapeutics Inc (OVID)


Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ironwood Pharma (NASDAQ:IRWD) and Ovid Therapeutics Inc (NASDAQ:OVID).

Ironwood Pharma (IRWD)

Cowen & Co. analyst Boris Peaker maintained a Hold rating on Ironwood Pharma today and set a price target of $21. The company’s shares opened today at $18.06.

According to TipRanks.com, Peaker is a 5-star analyst with an average return of 13.3% and a 47.5% success rate. Peaker covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals Inc, Stemline Therapeutics Inc, and Mersana Therapeutics Inc.

Currently, the analyst consensus on Ironwood Pharma is a Hold with an average price target of $18.30.

See today’s analyst top recommended stocks >>

Ovid Therapeutics Inc (OVID)

In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Ovid Therapeutics Inc. The company’s shares opened today at $6.99.

According to TipRanks.com, Baral is a top 100 analyst with an average return of 33.8% and a 54.3% success rate. Baral covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals Inc, Allena Pharmaceuticals Inc, and Global Blood Therapeutics.

Currently, the analyst consensus on Ovid Therapeutics Inc is a Moderate Buy with an average price target of $20.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts